12 reports

Global antirheumatics market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions and emergence of new diseases help increase the demand for various arthritis treatments. Global antirheumatics market is expected to be worth USD 56.88 billion by 2023. As per NAVADHI...

  • Pharmaceutical
  • Anti Rheumatic
  • World

Rheumatoid Arthritis Drugs Market by Drug Class (Disease-modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, and Others), Route of Administration (Oral and Parenteral), and Sales Channel (Prescription-based Drugs, and Over-the-counter Drugs): Global Opportunity Analysis and Industry...

  • Arthritis
  • Anti Rheumatic
  • World

Anti-Rheumatics Market by Drug Class (Disease Modifying Anti-Rheumatic Drugs (DMARD’s), Nonsteroidal Anti-Inflammatory Drugs (NSAID’s), Corticosteroids, Uric Acid Drugs, and Others), Type (Prescription-Based Drugs and Over-the-Counter Drugs): Global Opportunity Analysis and Industry Forecast, 2019–2026 The global anti-rheumatics...

  • Anti Rheumatic
  • Analgesic
  • Arthritis
  • World
  • APAC
  • Europe

Major players in the hydroxychloroquine market are Bayer AG, Dr. Reddy’s Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Wallace Pharma, Teva, Mylan, Novartis, and Intas Pharmaceuticals. The global hydroxychloroquine market is expected to grow from $718 million in 2019 to $980.1 million in 2020 at a compound annual growth rate (CAGR)...

  • Anti Rheumatic
  • World

China Anti Rheumatic

  • Salicylic Acid
  • Pain Relief
  • Anti Rheumatic
  • China
  • Labour Force
  • Industrial Production

China Anti Rheumatic

  • Salicylic Acid
  • Pain Relief
  • Anti Rheumatic
  • China
  • Labour Force
  • Industrial Production

China Anti Rheumatic

  • Anti Rheumatic
  • China
  • Industrial Production
  • Labour Force

General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - Section on recent mergers & acquisitions Treatment options for the AS include medication, exercise, physical...

  • Monoclonal Antibody
  • Anti Rheumatic
  • Autoimmune Disease
  • United States

General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapter segment - Section on recent mergers & acquisitions Current treatments of RA aim to relieve the symptoms of the disease...

  • Anti Rheumatic
  • Arthritis
  • Monoclonal Antibody
  • Autoimmune Disease
  • United States

Europe World Anti Rheumatic Lidocaine

  • Anti Rheumatic
  • Clinical Trial
  • World
  • Europe
  • United Kingdom
  • Medical Devices Sales
  • Energy Consumption

## Changes to Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs, 2015-2022

  • Therapy
  • Anti Rheumatic
  • Pharmaceutical
  • Arthritis
  • World
  • United States
  • North America
  • Mortality Rate

FIGURE ##: M##A ANTIRHEUMATIC N-STEROID ##

  • Healthcare
  • Analgesic
  • HIV Antiviral
  • Anti Rheumatic
  • Opioid
  • Romania
  • World
  • Direct Sales
  • Gross Domestic Product